Ligand validation:3LN1

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3LN1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3LN1_NAG_B_661	29%	35%	0.144	0.798	0.84	1.71	1	3	1	0	100%	0.9333
3LN1_NAG_A_681	27%	51%	0.137	0.781	0.48	1.39	-	2	0	0	100%	0.9333
3LN1_NAG_C_681	23%	46%	0.141	0.762	0.62	1.45	-	3	0	0	100%	0.9333
3LN1_NAG_B_681	16%	52%	0.168	0.739	0.64	1.19	-	1	1	0	100%	0.9333
3LN1_NAG_D_681	16%	44%	0.179	0.746	0.46	1.69	-	4	0	0	100%	0.9333
3LN1_NAG_C_661	15%	38%	0.159	0.718	0.63	1.75	-	4	1	0	100%	0.9333
3LN1_NAG_A_661	14%	29%	0.16	0.708	0.76	2.02	1	3	1	0	100%	0.9333
3LN1_NAG_D_661	13%	34%	0.171	0.708	0.8	1.76	1	4	1	0	100%	0.9333
6OFY_NAG_B_602	88%	26%	0.085	0.962	1.43	1.55	2	6	0	0	100%	0.9333
3RR3_NAG_B_671	83%	48%	0.081	0.951	0.68	1.31	-	2	4	0	93%	0.9333
6BL4_NAG_C_705	80%	83%	0.107	0.957	0.32	0.46	-	-	0	0	100%	0.9333
3Q7D_NAG_B_671	70%	40%	0.112	0.942	0.8	1.53	1	4	5	0	93%	0.9333
4OTJ_NAG_C_704	68%	83%	0.095	0.905	0.35	0.43	-	-	0	0	100%	0.9333
3H0C_NAG_A_796	100%	58%	0.02	0.995	0.47	1.12	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.